Gattefossé Corporate Headquarters
T: +33 4 72 22 98 00
E: infopharma@gattefosse.com
W: www.gattefosse.com

Gattefossé USA Regional Office
T: +201-265-4800
E: info@gattefossecorp.com 

 

COMPANY

Gattefossé provides innovative excipients to human and animal pharmaceutical industries, as well as to the dietary supplements industry. With a service and distribution network that spans over 12 affiliates, 40 distributors, and 90 countries, Gattefossé prides itself on having introduced innovative products tailored to formulators’ needs. We manufacture our products in France, Singapore, and in our new production site in Lufkin, Texas, to better serve our customers all over the world with equivalent high-quality standards.

PRODUCTS

Our lipid excipients are manufactured using vegetable oils, a wide array of plant-derived fatty acids, and alcohols such as polyglycerol, fatty alcohols, polyethylene glycol and propylene glycol. Depending on the raw materials used, the esterification reaction leads to solid, semi-solid, or liquid excipients. Through the selection of raw materials, the design and the control of the synthesis reaction, our oleochemists can develop high-quality, functional pharmaceutical excipients having targeted properties.

Our offer includes: 

• For oral route: bioavailability enhancers including dual-functional excipients that are both solubilizers and intestinal permeation enhancers such as Capryol® 90, Labrafac™ MC60 and Labrasol® ALF; lymphatic uptake promoters such as Maisine® CC, Peceol™, and the Labrafil™ series; lubricants for tablets (Compritol®) or for soft capsules (Labrafac™ Lipophile WL 1349); sustained-release agents (Compritol®, Geleol™ Mono and Diglycerides) ; as well as excipients for taste-masking and API protection (Precirol® ATO 5). Learn more about our oral excipient portfolio.
• For topical route: solubilizers and skin penetration enhancers such as Transcutol® P or Lauroglycol™, and a wide range of emulsifiers and co-emulsifiers to achieve topical dosage forms with improved textures. Learn more about our topical/transdermal excipient portfolio.
• For rectal and vaginal route: ready-to-use bases for suppositories and pessaries with our Suppocire® and Ovucire® lines. Learn more about our rectal/vaginal excipient portfolio.

PARTNERING WITH GATTEFOSSE

Gattefossé has built a solid scientific reputation with its functional excipients and their drug development applications. Continuous R&D investment and employment of highly qualified scientists demonstrate our commitment to providing customers worldwide with quality technical and regulatory support. A part of our technical expertise lies in our 4 Technical Centers of Excellence located in France, China, India, and the United States.

The main aims of these centers are to: 

• provide customer technical support
• characterize and optimize the performance of excipients in drug delivery systems and processes
• share knowledge through education and training

In Gattefossé tradition of knowledge sharing, we provide comprehensive technical documentation, including brochures, formulation guidelines, prototype formulations and videos. We also host regularly technical webinars to share with our customers the most updated information. All this technical documentation is freely available on our website.

INNOVATING WITH CARE AND RESPONSIBILITY

At Gattefossé, we innovate with care, guided by our Gatt’Up&Act roadmap—25 goals to be met by 2035 across three core pillars: Environment, Employees, and Society. We are committed to reducing our environmental impact, including a 25% cut in GHG emissions at our main site. Supporting employee growth is equally vital, with action plans focused on health and well-being for all. Social responsibility is embedded in our culture, with employees actively engaged in global volunteer efforts. Recognized with EcoVadis Gold and ISO 14001:2025 certification, our sustainable vision continues to inspire trust worldwide. Learn more on our website.